These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22746009)

  • 41. [Lymph node excision in differentiated thyroid carcinoma].
    Peparini N; Maturo A
    G Chir; 2004; 25(8-9):304-5; discussion 305. PubMed ID: 15560308
    [No Abstract]   [Full Text] [Related]  

  • 42. [The role of node-picking lymphadenectomy in the treatment of differentiated carcinoma of the thyroid].
    Nicolosi A; Malloci A; Esu S; Addis E; Tarquini A
    Minerva Chir; 1993 May; 48(9):459-63. PubMed ID: 8355874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggressive variants of papillary thyroid carcinoma.
    Silver CE; Owen RP; Rodrigo JP; Rinaldo A; Devaney KO; Ferlito A
    Head Neck; 2011 Jul; 33(7):1052-9. PubMed ID: 20824810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
    Fritze D; Doherty GM
    Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Apropos of prognostic factors in differentiated thyroid cancers (medullary excluded)].
    Hamoir M
    Ann Endocrinol (Paris); 1997; 58(6):510. PubMed ID: 9686011
    [No Abstract]   [Full Text] [Related]  

  • 48. Papillary carcinoma of the thyroid.
    Cady B
    Semin Surg Oncol; 1991; 7(2):81-6. PubMed ID: 2034944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.
    Xu B; Ghossein RA
    Histopathology; 2018 Jan; 72(1):32-39. PubMed ID: 28782127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Well differentiated thyroid carcinoma: epidemiology, etiology and treatment.
    Schimpff SC
    Am J Med Sci; 1979; 278(2):100-14. PubMed ID: 391042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The current problems and management strategy of standardized surgical treatment of differentiated thyroid carcinoma in China].
    Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 52(4):241-244. PubMed ID: 28441798
    [No Abstract]   [Full Text] [Related]  

  • 52. Thyroid cancer - a surgeon's view.
    Staunton MD
    Ann Acad Med Singap; 1981 Apr; 10(2):203-7. PubMed ID: 7332285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Combined Bronchoscopic Interventions with Percutaneous Implantations of Radioactive Seeds & Release-controlled Chemical Drugs for Treatment of Patients with Papillary Thyroid Carcinoma and Invasion of Trachea.].
    Wang H; Zhou Y; Luo L; Ma H; Zou H; Zhang N; Li D; Li J
    Zhongguo Fei Ai Za Zhi; 2009 Jul; 12(7):831-4. PubMed ID: 20719165
    [No Abstract]   [Full Text] [Related]  

  • 54. Low-risk thyroid carcinoma: when is the treatment worse than the disease?
    Potenza M; Mechanick JI
    Expert Rev Endocrinol Metab; 2009 Jan; 4(1):5-7. PubMed ID: 30934376
    [No Abstract]   [Full Text] [Related]  

  • 55. Carbon nanoparticles facilitate lymph nodes dissection and parathyroid glands identification in reoperation of papillary thyroid cancer.
    Su AP; Wang B; Gong YP; Wu WS; Gong RX; Li ZH; Zhu JQ
    Medicine (Baltimore); 2017 Nov; 96(44):e8380. PubMed ID: 29095266
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aggressive Disease Course of Papillary Thyroid Carcinoma with Focal Undifferentiated Component: A Case Report.
    Riaz S; Bashir H; Hassan A; Mushtaq S; Jamshed A; Murtaza A
    Mol Imaging Radionucl Ther; 2016 Oct; 25(3):134-139. PubMed ID: 27751976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.
    He LY; Wang WW; Ibrahima BA; Han S; Li Z; Cai Z; Chen ML; Chen BZ; Tan HS; Zeng HS; Dai XL; Zhou MW; Zhang GQ; Li GX
    Medicine (Baltimore); 2016 Oct; 95(41):e5034. PubMed ID: 27741112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy comparison of the anterior low small incision and the traditional incision for treatment of thyroid adenoma.
    Zhang Z
    Pak J Med Sci; 2014 Sep; 30(5):1119-22. PubMed ID: 25225538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical treatment of papillary thyroid carcinoma.
    Abboud B; Tannoury J
    J Med Liban; 2011; 59(4):206-12. PubMed ID: 22746009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.